Zoetis (NY: ZTS )
157.95 USD +0.88 (+0.56%) Official Closing Price Updated: 7:00 PM EST, Dec 4, 2020 Add to My Watchlist
Press releases about Zoetis
Zoetis Named One of the “Top 75 Companies for Executive Women” by Working Mother Media
December 01, 2020
For the third year in a row, Zoetis has been named one of the "Top 75 Companies for Executive Women" by Working Mother Media.
Zoetis is First Animal Health Company to Issue Environmental, Social and Governance (ESG) Review Based on Leading Sustainability Frameworks
November 16, 2020
Zoetis is the first animal health company to issue Environmental, Social and Governance (ESG) Review based on leading sustainability frameworks.
Zoetis Receives European Commission Marketing Authorization for Librela® (bedinvetmab)
November 12, 2020
Zoetis has received European Commission Marketing Authorization for Librela (bedinvetmab) for alleviation of osteoarthritis (OA) pain in dogs
Zoetis Announces Third Quarter 2020 Results
November 05, 2020
Zoetis Declares Fourth Quarter 2020 Dividend
October 07, 2020
Zoetis to Host Webcast and Conference Call on Third Quarter 2020 Financial Results
September 30, 2020
Zoetis Named a Top Company for Working Mothers
September 15, 2020
For the seventh year in a row, Zoetis has been named one of Working Mother Magazine's 100 Best Companies for Working Mothers.
Zoetis Announces Second Quarter 2020 Results
August 06, 2020
US Stocks That Surged To All-Time High: $ZTS $EQIX $CNI
August 06, 2020
Tags The Market Signal
From The Market Signal
Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health
July 07, 2020
Trianni, Inc. (TRIANNI) and Zoetis (NYSE: ZTS) today announced a collaboration for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments.
From PR Newswire
Zoetis Announces Results of Its Annual Meeting of Shareholders; Board Declares Third Quarter 2020 Dividend
May 20, 2020
Zoetis announces results of Its annual meeting of shareholders and declares third quarter 2020 dividend.
Zoetis Announces First Quarter 2020 Results
May 06, 2020
Zoetis Recommends Stockholders Reject Below-Market Mini-Tender Offer by TRC Capital Investment Corporation
April 17, 2020
Zoetis recommends stockholders reject below-market mini-tender offer by TRC Capital Investment Corporation.
Zoetis to host webcast and conference call on first quarter 2020 financial results on Wednesday, May 6.
Zoetis Named a Top Company for Executive Women by NAFE
March 03, 2020
Zoetis named one of the 2020 “Top 70 Companies for Executive Women” by the National Association for Female Executives.
Zoetis Receives FDA Approval for Simparica Trio™, A New Combination Parasite Preventative for Dogs
February 27, 2020
Zoetis has received FDA approval for Simparica Trio, a new combination parasite preventative for dogs.
Zoetis Inc. (NYSE:ZTS) will participate in the Cowen and Company 40th Annual Health Care Conference on Monday, March 2, 2020, in Boston, Mass. Kristin Peck, Chief Executive Officer, will represent the...
Zoetis Reports Fourth Quarter and Full Year 2019 Results
February 13, 2020
Zoetis Declares Second Quarter 2020 Dividend
February 11, 2020
Zoetis Acquires Ethos Diagnostic Science, a Veterinary Reference Lab Business, to Further Expand its Comprehensive Diagnostics Capabilities
February 07, 2020
Zoetis acquires Ethos Diagnostic Science, a veterinary reference lab business, to further expand its comprehensive diagnostics capabilities.
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2019 Financial Results
January 02, 2020